Boc-Tdf-OH
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-Tdf-OH

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
BOC-Amino Acids
Catalog number
BAT-000903
CAS number
92367-17-4
Molecular Formula
C16H18F3N3O4
Molecular Weight
373.33
IUPAC Name
(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-[4-[3-(trifluoromethyl)diazirin-3-yl]phenyl]propanoic acid
Synonyms
(S)-2-(t-Butoxycarbonylamino)-3-(4-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenyl)propanoic acid; N-α-(t-Butoxycarbonyl)-4-[3-(trifluoromethyl)-3H-diazirin-3-yl]-L-phenylalanine; Boc-Phe[4-{3-Diazirin(3-CF3)}]-OH
Storage
Store at 2-8 °C
InChI
InChI=1S/C16H18F3N3O4/c1-14(2,3)26-13(25)20-11(12(23)24)8-9-4-6-10(7-5-9)15(21-22-15)16(17,18)19/h4-7,11H,8H2,1-3H3,(H,20,25)(H,23,24)/t11-/m0/s1
InChI Key
WYABUBZWZAONDD-NSHDSACASA-N
Canonical SMILES
CC(C)(C)OC(=O)NC(CC1=CC=C(C=C1)C2(N=N2)C(F)(F)F)C(=O)O
1. From {Bi22O26} to chiral ligand-protected {Bi38O45}-based bismuth oxido clusters
Dirk Mansfeld, et al. Chemistry. 2011 Dec 23;17(52):14805-10. doi: 10.1002/chem.201102437. Epub 2011 Nov 25.
The reaction of [Bi(22)O(26)(OSiMe(2)tBu)(14)] (1) in THF with salicylic acid gave [Bi(22)O(24)(HSal)(14)] (2) first, which was converted into [Bi(38)O(45)(HSal)(22)(OH)(2)(DMSO)(16.5)]·DMSO·H(2)O (3·DMSO·H(2)O) after dissolution and crystallization from DMSO. Single-crystal X-ray diffraction analysis and ESI mass spectrometry associated with infrared multi-photon dissociation (IRMPD) tandem MS experiments confirm the formation of the large and quite stable bismuth oxido cluster 3. The reaction of compound 2 with the butoxycarbonyl(BOC)-protected amino acids phenylalanine and valine (BOC-PheOH and BOC-ValOH), respectively, resulted in the formation of chiral [Bi(38)O(45)(BOC-AA)(22)(OH)(2)] (AA=deprotonated amino acid), as shown by a combination of different analytical techniques such as elemental analysis, dynamic light scattering, circular dichroism spectroscopy, and ESI mass spectrometry.
2. Modelling the site of bromide binding in vanadate-dependent bromoperoxidases
Verena Kraehmer, Dieter Rehder Dalton Trans. 2012 May 7;41(17):5225-34. doi: 10.1039/c2dt12287a. Epub 2012 Mar 14.
Treatment of Boc-protected (S)-serine (Ser) methyl ester with triphenylphosphine bromide Ph(3)PBr (intermittently generated from PPh(3) and N-bromosuccinimide) yields Boc-3-bromoalanine (R)-Boc-BrAlaMe and, after deprotection, bromoalanine methyl ester (R)-BrAlaMe in the form of its hydrobromide. Boc-BrAlaMe and BrAlaMe have been structurally characterised. The reaction between BrAlaMe, salicylaldehyde (sal) and VO(2+) results in the formation of Schiff base complexes of composition [VO(sal-BrAlaMe)solv](+) (solv = CH(3)OH: 3, THF: 5) and [VO(sal-BrAla)THF] 4. DFT calculations of the structures of 3, 4 and 5, based on the B3LYP functional and employing the triple zeta basis set 6-311++g(d,p), provide distances Br···V = 4.0 ± 0.1 Å, if some distortion of the dihedral angle ∠N-C-C-Br is allowed (affording a maximum energy of ca. 45 kJ mol(-1)), and thus model Br···V distances detected by X-ray methods in bromoperoxidases from the marine algae Ascophyllum nodosum and Corallina pilulifera. The DFT calculations have been validated by comparing calculated and found structures, including the new complex [V(V)O(Amp-sal)OMe(MeOH)] (1, Amp is the aminophenol moiety) and the known complex [VO(L-Ser-van)H(2)O] (van = vanillin). Additional validation has been undertaken by checking experimental against calculated (BHandHLYP) EPR spectroscopic hyperfine coupling constants. Complexes containing bromine as a substituent at the phenyl moiety of a Schiff base ligand do not allow for an appropriate simulation of the Br···V distance in peroxidases. The closest agreement, d(Br···V) = 4.87 Å, is achieved with [VO(3Br-salSer)THF] (6), where 3Brsal-Ser is the dianionic Schiff base formed between 3-Br-5-NO(2)-salicylaldehyde and serine.
3. Synthetic studies on (-)-lemonomycin: an efficient asymmetric synthesis of lemonomycinone amide
Yan-Chao Wu, Guillaume Bernadat, Géraldine Masson, Cédric Couturier, Thierry Schlama, Jieping Zhu J Org Chem. 2009 Mar 6;74(5):2046-52. doi: 10.1021/jo8027449.
Asymmetric synthesis of lemonomycinone amide (2) was accomplished from readily accessible starting materials. Enantioselective alkylation of N-(diphenylmethylene)glycine tert-butyl ester (11) by 5-tert-butyldimethylsilyloxy-2,4-dimethoxy-3-methylbenzyl bromide (10) in the presence of Corey-Lygo's phase transfer catalyst [O-(9)-ally-N-(9'-anthracenylmethyl) cinchonidium bromide, 0.1 equiv] afforded, after chemoselective hydrolysis of the imine function (THF/H(2)O/AcOH), the substituted l-tert-butyl phenylalanate 13 in 85% yield. A Pictet-Spengler reaction of 14 with benzyloxyacetaldehyde (15) provided the 1,3-cis-disubstituted tetrahydroisoquinoline 16 in 85% yield as a single diastereomer. Coupling of hindered secondary amine 16 with amino acid 9 was accomplished under carefully controlled conditions to furnish the amide 22, which was in turn converted to hemiaminal 24. A hafnium triflate catalyzed conversion of hemiaminal to alpha-amino thioether followed by a silver tetrafluoroborate promoted intramolecular Mannich reaction of 26 afforded the tetracycle 27 in excellent overall yields. Debenzylation of 27 [Pd(OH)(2), H(2), MeOH, 0 degrees C], removal of N-Boc function (aqueous 3 N HCl, MeOH/H(2)O), and oxidation of hydroquinone to quinone [(NH(4))(2)Ce(NO(3))(6), H(2)O, rt] afforded the lemonomycinone amide 2 in 76% yield over three steps.
Online Inquiry
Verification code
Inquiry Basket